Equities
Health CareHealth Care Providers
  • Price (USD)217.73
  • Today's Change-2.82 / -1.28%
  • Shares traded880.48k
  • 1 Year change-17.13%
  • Beta1.3778
Data delayed at least 15 minutes, as of Dec 02 2022 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions and real-world insights and services to the Company's life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, providing outsourced clinical research and clinical trial related services. The Contract Sales & Medical Solutions segment provides health care provider, including contract sales and patient engagement services to both biopharmaceutical clients and the broader healthcare market. The Company protects individual patient privacy. The Company conducts business in more than 100 countries.

  • Revenue in USD (TTM)14.31bn
  • Net income in USD1.18bn
  • Incorporated2016
  • Employees83.00k
  • Location
    IQVIA Holdings Inc4820 Emperor BlvdDURHAM 27703United StatesUSA
  • Phone+1 (919) 998-2000
  • Fax+1 (302) 636-5454
  • Websitehttps://ir.iqvia.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IQV:NYQ since
announced
Transaction
value
Pharmaspectra LLCDeal completed14 Aug 202214 Aug 2022Deal completed-11.42%--
Data delayed at least 15 minutes, as of Dec 02 2022 21:10 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Seagen Inc1.86bn-636.77m22.73bn2.68k--8.04--12.19-3.46-3.4610.1415.230.49081.424.27696,864.70-16.76-5.22-20.63-6.0079.1687.67-34.16-9.783.30-142.610.00---27.6330.36-209.91--13.46--
Horizon Therapeutics PLC3.70bn574.26m23.76bn2.10k43.124.7624.696.422.432.4315.6822.010.41984.315.211,958,455.006.513.937.214.6475.1271.3715.5110.983.749.490.33760.0046.6326.8837.12--37.25--
Gartner Inc5.28bn760.34m27.82bn16.60k37.96--29.125.279.279.2764.37-0.82010.7807--5.11317,918.8011.254.1220.197.0669.3465.0014.416.65--15.861.03--15.4814.13197.5032.603.71--
Alnylam Pharmaceuticals, Inc.960.92m-1.18bn28.84bn1.67k------30.01-9.77-9.777.95-0.54990.27431.456.86577,127.90-33.74-32.56-42.04-37.9483.85---123.02-223.643.33-2.761.07--71.3178.070.6358--3.42--
DuPont de Nemours Inc14.18bn1.16bn35.55bn28.00k31.271.4314.272.512.293.6327.8450.150.31483.545.49506,571.402.71-0.22273.11-0.289235.0531.608.62-1.611.995.110.3173--16.15-19.13172.14-15.09-25.20-26.30
Iqvia Holdings Inc14.31bn1.18bn40.44bn83.00k35.437.5718.152.836.156.1574.4328.780.593--5.76181,101.304.941.776.252.1434.7234.308.343.64--5.190.69860.0022.1415.28246.2468.0831.30--
Data as of Dec 02 2022. Currency figures normalised to IQVIA Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

33.91%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202220.47m11.02%
BlackRock Fund Advisorsas of 30 Sep 202210.29m5.54%
SSgA Funds Management, Inc.as of 30 Sep 20228.61m4.64%
AllianceBernstein LPas of 30 Sep 20225.16m2.78%
Geode Capital Management LLCas of 30 Sep 20223.63m1.96%
Farallon Capital Management LLCas of 30 Sep 20223.21m1.73%
Columbia Management Investment Advisers LLCas of 30 Sep 20223.20m1.72%
Canada Pension Plan Investment Boardas of 30 Sep 20223.09m1.67%
Lazard Asset Management LLCas of 30 Sep 20222.81m1.52%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 20222.50m1.35%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.